Med. pract. Stefanie Müller
Neurologie · Dept. III
Heart rate variability decreases after 3 months of sustained treatment with fingolimod in patients with multiple sclerosis: a prospective clinical trial
Vehoff J, Hägele-Link S, Humm A, Müller S, Sauter R, Tettenborn B, Hundsberger T (2017). Heart rate variability decreases after 3 months of sustained treatment with fingolimod in patients with multiple sclerosis: a prospective clinical trial.
25.06.2017Heart rate variability decreases after 3 months of sustained treatment with fingolimod in patients with multiple sclerosis: a prospective clinical trial
25.06.20173rd EAN Congress
Vehoff Jochen, Hägele-Link Stefan, Humm Andrea, Müller Stefanie, Sauter Rafael, Tettenborn Barbara, Hundsberger Thomas
The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography
Pardini M, Putzki N, Tettenborn B, Valmaggia C, Gass A, Würfel J, Ruberte E, Kuhle J, Vehoff J, Müller S, Botzkowski D, Yaldizli O. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography. Eur J Neurol 2016
03.09.2016The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography
03.09.2016Eur J Neurol 2016
Pardini M, Putzki N, Tettenborn Barbara, Valmaggia Christophe, Gass A, Würfel J, Ruberte E, Kuhle J, Vehoff Jochen, Müller Stefanie, Botzkowski D, Yaldizli O
Role of family planning in women of child-bearing age with multiple sclerosis (MS) in Switzerland: Results of the Women
Muehl S, Czaplinski A, Stelmess P, Kamm C, Müller S (2016). Role of family planning in women of child-bearing age with multiple sclerosis (MS) in Switzerland: Results of the Women.
17.04.2016Role of family planning in women of child-bearing age with multiple sclerosis (MS) in Switzerland: Results of the Women
17.04.2016American Academy of Neurology AAN
Muehl Sarah, Czaplinski Adam, Stelmess Petra, Kamm Christian P., Müller Stefanie
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options
Giulio D, Kamm C, Mattle H, Lotter C, Du Pasquier R, Schluep M, Pot C, Lalive P, Yaldizli O, Gobbi C, Kappos L, Kuhle J, Louvion J, Derfuss T, Stippich C, Benkert P, Lorscheider J, Müller S, Vehoff J, Zecca C, Ramseier S, Achtnichts L, Findling O, Nedeltchev K, Radue E, Sprenger T, SMSC Scientific Board. The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options. PloS one 2016; 11:e0152347.
31.03.2016The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options
31.03.2016PloS one 2016; 11:e0152347
Giulio Disanto, Kamm Christian P, Mattle Heinrich P, Lotter Christoph, Du Pasquier Renaud, Schluep Myriam, Pot Caroline, Lalive Patrice H, Yaldizli Ozgür, Gobbi Claudio, Kappos Ludwig, Kuhle Jens, Louvion Jean-François, Derfuss Tobias, Stippich Christoph, Benkert Pascal, Lorscheider Johannes, Müller Stefanie, Vehoff Jochen, Zecca Chiara, Ramseier Simon, Achtnichts Lutz, Findling Oliver, Nedeltchev Krassen, Radue Ernst-Wilhelm, Sprenger Till, SMSC Scientific Board
Behandlung eines Multiple-Sklerose-Schubs - Orale versus intravenöse Steroide
Müller S. Behandlung eines Multiple-Sklerose-Schubs - Orale versus intravenöse Steroide. InFo NEUROLOGIE & PSYCHIATRIE 2015; Vol. 14, Nr. 1 2015; Vol. 14:5-5.
15.12.2015Behandlung eines Multiple-Sklerose-Schubs - Orale versus intravenöse Steroide
15.12.2015InFo NEUROLOGIE & PSYCHIATRIE 2015; Vol. 14, Nr. 1 2015; Vol. 14:5-5
Müller Stefanie
Glioblastoma multiforme: Chameleon of neurology A case report
Prochnicki A, Zieglgänsberger D, Vehoff J, Müller S, Tettenborn B, Hundsberger T (2015). Glioblastoma multiforme: Chameleon of neurology A case report.
30.10.2015Glioblastoma multiforme: Chameleon of neurology A case report
30.10.2015SNG Tagung 2015
Prochnicki Anita, Zieglgänsberger Dominik, Vehoff Jochen, Müller Stefanie, Tettenborn Barbara, Hundsberger Thomas
Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series
Engeler D, Meyer D, Abt D, Müller S, Schmid H. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series. BMC Urol 2015; 15:105.
23.10.2015Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series
23.10.2015BMC Urol 2015; 15:105
Engeler Daniel, Meyer Daniel, Abt Dominik, Müller Stefanie, Schmid Hans-Peter
Brain metabolites and retinal nerve fibre layer thickness and their relation to disability in multiple sclerosis: a longitudinal high-field proton magnetic resonance spectroscopy and optical coherence tomography study
Pardini M, Putzki N, Tettenborn B, Valmaggia C, Würfel J, Gass A, Kuhle J, Vehoff J, Müller S, Botzkowski D, Yaldizli O (2015). Brain metabolites and retinal nerve fibre layer thickness and their relation to disability in multiple sclerosis: a longitudinal high-field proton magnetic resonance spectroscopy and optical coherence tomography study.
07.10.2015Brain metabolites and retinal nerve fibre layer thickness and their relation to disability in multiple sclerosis: a longitudinal high-field proton magnetic resonance spectroscopy and optical coherence tomography study
07.10.2015ECTRIMS 2015
Pardini M., Putzki Norman, Tettenborn Barbara, Valmaggia Christophe, Würfel Jens, Gass Andrea, Kuhle Jens, Vehoff Jochen, Müller Stefanie, Botzkowski D., Yaldizli Ozgür
The Swiss multiple sclerosis cohort study: a prospective nationwide investigation of disease evolution and the effects of new disease modifying drugs
Disanto G, Derfuss T, Louvion J, Kamm C, Mattle H, Lotter C, du Pasquier R, Schluepp M, Pot C, Lalive P, Kappos L, Stippich C, Sprenger T, Benkert P, Lohrscheider J, Müller S, Vehoff J, Zecca C, Ramseier S, Achnichts L, Findling O, Nedeltchev K, Radue E, Kuhle J (2015). The Swiss multiple sclerosis cohort study: a prospective nationwide investigation of disease evolution and the effects of new disease modifying drugs.
23.09.2015The Swiss multiple sclerosis cohort study: a prospective nationwide investigation of disease evolution and the effects of new disease modifying drugs
23.09.2015ECTRIMS 2015
Disanto G., Derfuss T., Louvion J.-F., Kamm C., Mattle H.P., Lotter C., du Pasquier R., Schluepp M., Pot C., Lalive P.H., Kappos L., Stippich C., Sprenger T., Benkert P., Lohrscheider J., Müller Stefanie, Vehoff Jochen, Zecca C., Ramseier S., Achnichts L., Findling O., Nedeltchev K., Radue E.W., Kuhle J.
Neurocognitive changes in patients with relapsing-remitting multiple sclerosis treated with natalizumab
Döhler N, Müller S, Vehoff J, Galovic M, Tettenborn B (2014). Neurocognitive changes in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
10.09.2014Neurocognitive changes in patients with relapsing-remitting multiple sclerosis treated with natalizumab
10.09.2014ECTRIMS 2014
Döhler Nico, Müller Stefanie, Vehoff Jochen, Galovic Marian, Tettenborn Barbara
Swiss analysis of multiple sclerosis: a multicenter, non-interventional, retrospective cohort study of disease-modifying therapies
Gobbi C, Zecca C, Linnebank M, Müller S, You X, Meier R, Borter E, Traber M. Swiss analysis of multiple sclerosis: a multicenter, non-interventional, retrospective cohort study of disease-modifying therapies. Eur Neurol 2013; 70:35-41.
14.05.2013Swiss analysis of multiple sclerosis: a multicenter, non-interventional, retrospective cohort study of disease-modifying therapies
14.05.2013Eur Neurol 2013; 70:35-41
Gobbi Claudio, Zecca Chiara, Linnebank Michael, Müller Stefanie, You Xiaojun, Meier Rosetta, Borter Emmanuela, Traber Martin
Multiple sclerosis associated fatigue during disease modifying treatment with natalizumab, interferon-beta and glatirameracetate: 1 year follow-up
Yildiz M, Müller S, Vehoff J, Tettenborn B (2011). Multiple sclerosis associated fatigue during disease modifying treatment with natalizumab, interferon-beta and glatirameracetate: 1 year follow-up.
09.04.2011Multiple sclerosis associated fatigue during disease modifying treatment with natalizumab, interferon-beta and glatirameracetate: 1 year follow-up
09.04.2011AAN
Yildiz Murat, Müller Stefanie, Vehoff Jochen, Tettenborn Barbara
Multiple Sklerose: Neue Diagnosekriterien und neue Therapiemöglichkeiten
Vehoff J, Müller S, Tettenborn B. Multiple Sklerose: Neue Diagnosekriterien und neue Therapiemöglichkeiten. InFo Neurologie & Psychiatrie 2011; Vol.9
01.04.2011Multiple Sklerose: Neue Diagnosekriterien und neue Therapiemöglichkeiten
01.04.2011InFo Neurologie & Psychiatrie 2011; Vol.9
Vehoff Jochen, Müller Stefanie, Tettenborn Barbara
Koinzidenz von ischämischer Enzephalopathie und essentieller Thrombozythämie: zerebrale kortikale Venenthrombose ?
Hundsberger T, Müller S, Sommacal A, Fretz C, Tettenborn B. Koinzidenz von ischämischer Enzephalopathie und essentieller Thrombozythämie: zerebrale kortikale Venenthrombose ?. S C H W E I Z E R A R C H I V F Ü R N E U R O L O G I E U N D P S Y C H I A T R I E 2010; 161:262-265.
08.11.2010Koinzidenz von ischämischer Enzephalopathie und essentieller Thrombozythämie: zerebrale kortikale Venenthrombose ?
08.11.2010S C H W E I Z E R A R C H I V F Ü R N E U R O L O G I E U N D P S Y C H I A T R I E 2010; 161:262-265
Hundsberger Thomas, Müller Stefanie, Sommacal Andreas, Fretz Christian, Tettenborn Barbara
Abnormal sleep/wake-patterns in
Müller S, Bönig L, von Manitius S, Weder B, Tettenborn B (2009). Abnormal sleep/wake-patterns in. Präsentiert bei: 173. Tagung der Schweizerischen Neurologischen Gesellschaft in Luzern, -
21.10.2009Abnormal sleep/wake-patterns in
21.10.2009173. Tagung der Schweizerischen Neurologischen Gesellschaft in Luzern
Müller Stefanie, Bönig L., von Manitius S., Weder B., Tettenborn Barbara
Spontaneous internal carotid artery dissection presenting as hypoglossal nerve palsy
Vehoff J, Müller S (2009). Spontaneous internal carotid artery dissection presenting as hypoglossal nerve palsy. Präsentiert bei: Gemeinsame Jahrestagung Schweizerische Neurologische Gesellschaft SNG (182. Tagung), Interlaken
01.04.2009Spontaneous internal carotid artery dissection presenting as hypoglossal nerve palsy
01.04.2009Gemeinsame Jahrestagung Schweizerische Neurologische Gesellschaft SNG (182. Tagung)
Vehoff Jochen, Müller Stefanie
Anti-Hu syndrome preceding a carcinoma of the vocal cords
Müller S, Endress E, Schött D, Hägele-Link S (2006). Anti-Hu syndrome preceding a carcinoma of the vocal cords. Präsentiert bei: 177. Tagung der Schweizerischen Neurologischen Gesellschaft (Interlaken), -
21.12.2006Anti-Hu syndrome preceding a carcinoma of the vocal cords
21.12.2006177. Tagung der Schweizerischen Neurologischen Gesellschaft (Interlaken)
Müller Stefanie, Endress E.M., Schött D., Hägele-Link Stefan
Anti-Hu syndrome preceding a carcinoma of the vocal cords
Müller S, Endress E, Schött D, Hägele-Link S, Tettenborn B (2006). Anti-Hu syndrome preceding a carcinoma of the vocal cords. Präsentiert bei: 177. Tagung Schweiz. Neurologischen Gesellschaft, Interlaken
21.12.2006Anti-Hu syndrome preceding a carcinoma of the vocal cords
21.12.2006177. Tagung Schweiz. Neurologischen Gesellschaft
Müller Stefanie, Endress EM, Schött Dagmar, Hägele-Link Stefan, Tettenborn Barbara
Wound botulism in an injection drug user
Müller S, Tettenborn B, Bönig L (2005). Wound botulism in an injection drug user. Präsentiert bei: 176. Tagung der Schweizerischen Neurologischen Gesellschaft (St. Gallen), -
27.10.2005Wound botulism in an injection drug user
27.10.2005176. Tagung der Schweizerischen Neurologischen Gesellschaft (St. Gallen)
Müller Stefanie, Tettenborn Barbara, Bönig Lutz
Hereditary transthyretin amyloidosis:a case report of a newly described TTR variant Ile 107Met
Müller S, Tettenborn B, Schött D, Altland K (2004). Hereditary transthyretin amyloidosis:a case report of a newly described TTR variant Ile 107Met. Präsentiert bei: 172. Tagung der Schweizerischen Neurologischen Gesellschaft (Interlaken), 172. Tagung der Schweizerischen Neurologischen Gesellschaft (Interlaken)
21.12.2004Hereditary transthyretin amyloidosis:a case report of a newly described TTR variant Ile 107Met
21.12.2004172. Tagung der Schweizerischen Neurologischen Gesellschaft (Interlaken)
Müller Stefanie, Tettenborn Barbara, Schött Dagmar, Altland K.